Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia

Posaconazole tablets, a new oral formulation of posaconazole, can be effective when given as antifungal prophylaxis to neutropenic patients at high risk for invasive fungal infection (e.g., those with acute myelogenous leukemia or myelodysplastic syndrome). Such effectiveness might be specifically i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Duarte, Rafael F., López-Jiménez, Javier, Cornely, Oliver A., Laverdiere, Michel, Helfgott, David, Haider, Shariq, Chandrasekar, Pranatharthi, Langston, Amelia, Perfect, John, Ma, Lei, van Iersel, Marlou L. P. S., Connelly, Nancy, Kartsonis, Nicholas, Waskin, Hetty
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4187965/
https://ncbi.nlm.nih.gov/pubmed/25049247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03050-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados